Description

Drugs are authorized for sale in Canada once they have successfully gone through the drug review process, which includes the assessment of the safety, efficacy and quality of the drug. However, Health Canada's SAP allows practitioners to request access to drugs that are not available in Canada for the emergency treatment of patients with serious or life-threatening conditions who have exhausted other treatment options.

Resources

Name	Format	Description	Link
Notice: Clarifications Regarding Access to Restricted Drugs through the Special Access Program (SAP)	HTML		https://www.canada.ca/en/health-canada/services/drugs-health-products/special-access/notice-clarifications-regarding-restricted-drugs-program.html
Notice: Clarifications Regarding Access to Restricted Drugs through the Special Access Program (SAP)	HTML		https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/acces-special/avis-clarifications-concernant-drogues-usage-restreint-biais-programme.html

Tags

Topics

Categories